These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29069710)

  • 21. Initial nasolacrimal duct probing in children under age 5: cure rate and factors affecting success.
    Kashkouli MB; Kassaee A; Tabatabaee Z
    J AAPOS; 2002 Dec; 6(6):360-3. PubMed ID: 12506276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buried Probe in Complex Congenital Nasolacrimal Duct Obstructions: Clinical Profiles and Outcomes.
    Gupta A; Kamal S; Javed Ali M; Naik MN
    Ophthalmic Plast Reconstr Surg; 2015; 31(4):318-20. PubMed ID: 25417795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of probing for children with congenital nasolacrimal duct obstruction: a retrospective study using fluorescein dye disappearance test and lacrimal sac echography.
    Steindler P; Mantovani E; Incorvaia C; Parmeggiani F
    Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):837-46. PubMed ID: 19107503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of balloon dacryocystoplasty to probing as the primary treatment of congenital nasolacrimal duct obstruction.
    Gunton KB; Chung CW; Schnall BM; Prieto D; Wexler A; Koller HP
    J AAPOS; 2001 Jun; 5(3):139-42. PubMed ID: 11404738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors Predictive of Success in Probing for Congenital Nasolacrimal Duct Obstruction.
    Beato J; Mota Á; Gonçalves N; Santos-Silva R; Magalhães A; Breda J; Falcão-Reis F
    J Pediatr Ophthalmol Strabismus; 2017 Mar; 54(2):123-127. PubMed ID: 27977034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital Nasolacrimal Duct Obstruction: Comparison of Two Different Treatment Algorithms.
    Napier ML; Armstrong DJ; McLoone SF; McLoone EM
    J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):285-91. PubMed ID: 27486727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of nasolacrimal duct probing in children between 9-48 months.
    Medghalchi A; Mohammadi MJ; Soltani Moghadam R; Dalili H
    Acta Med Iran; 2014; 52(7):545-51. PubMed ID: 25135264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simple vs complex congenital nasolacrimal duct obstructions: etiology, management and outcomes.
    Ali MJ; Kamal S; Gupta A; Ali MH; Naik MN
    Int Forum Allergy Rhinol; 2015 Feb; 5(2):174-7. PubMed ID: 25367436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of Congenital Nasolacrimal Duct Obstruction with Probing, Experience in a Mexican Eye Center.
    Zuazo F; Morales OO; Tovilla ML; Castañeda ÁN
    Nepal J Ophthalmol; 2019 Jul; 11(22):189-196. PubMed ID: 32792696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of treatment modalities and prognostic factors in children with congenital nasolacrimal duct obstruction.
    Al-Faky YH; Al-Sobaie N; Mousa A; Al-Odan H; Al-Huthail R; Osman E; Al-Mosallam AR
    J AAPOS; 2012 Feb; 16(1):53-7. PubMed ID: 22370666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of metal-metal contact during nasolacrimal duct probing.
    Mocan MC; Gulmez Sevim D; Kocabeyoglu S; Irkec M
    Can J Ophthalmol; 2015 Aug; 50(4):314-7. PubMed ID: 26257227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of late probing for congenital nasolacrimal duct obstruction in Singapore children.
    Yap EY; Yip CC
    Int Ophthalmol; 1997-1998; 21(6):331-4. PubMed ID: 9869342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nasal endoscopic visualization and management of the leading causes of probing failure.
    Hakim OM; Mandour W; Elbaz E
    J Pediatr Ophthalmol Strabismus; 2010; 47(4):214-9. PubMed ID: 20635812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoscopic assisted probing for symptomatic congenital nasolacrimal duct obstruction after one year of age.
    Elmorsy S; Shabana YK; Fayek HM
    Rhinology; 2010 Mar; 48(1):100-3. PubMed ID: 21480567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Success rates of primary probing for congenital nasolacrimal obstruction in children.
    Arora S; Koushan K; Harvey JT
    J AAPOS; 2012 Apr; 16(2):173-6. PubMed ID: 22525175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasolacrimal duct intubation in the treatment of congenital nasolacrimal duct obstruction in older children.
    Okumuş S; Öner V; Durucu C; Coşkun E; Aksoy Ü; Durucu E; Şahin L; Erbağcı I
    Eye (Lond); 2016 Jan; 30(1):85-8. PubMed ID: 26449195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Congenital nasolacrimal duct obstruction from an ophthalmologist's point of view : Causes, diagnosis and staged therapeutic concept].
    Heichel J; Bredehorn-Mayr T; Struck HG
    HNO; 2016 Jun; 64(6):367-75. PubMed ID: 26912049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital Nasolacrimal Duct Obstruction Update Study (CUP Study): Report III. Analysis of Earlier Failed Probing without Endoscopy Guidance.
    Bothra N; Bansal O; Sharma A; Ali MJ
    Semin Ophthalmol; 2022 Feb; 37(2):249-252. PubMed ID: 34606409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of endoscopic assisted probing for congenital nasolacrimal duct obstruction in older children.
    Kouri AS; Tsakanikos M; Linardos E; Nikolaidou G; Psarommatis I
    Int J Pediatr Otorhinolaryngol; 2008 Jun; 72(6):891-6. PubMed ID: 18440076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dilation probing as primary treatment for congenital nasolacrimal duct obstruction.
    Clark RA
    J AAPOS; 2002 Dec; 6(6):364-7. PubMed ID: 12506277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.